SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-017052
Filing Date
2024-04-29
Accepted
2024-04-29 17:23:33
Documents
7
Period of Report
2024-04-29

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 464228
2 formdef14a_001.jpg GRAPHIC 6692
3 formdef14a_002.jpg GRAPHIC 1341
4 formdef14a_003.jpg GRAPHIC 102259
5 proxy_001.jpg GRAPHIC 515372
6 proxy_002.jpg GRAPHIC 730088
7 proxy_003.jpg GRAPHIC 467167
  Complete submission text file 0001493152-24-017052.txt   2976483
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37648 | Film No.: 24892909
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)